Dawson Reimer, President & COO, Tel. 888-435-2220, Fax 204-488-9823, E-mail: info@medicure.com, www.medicure.comCopyright CNW Group 2015
Medicure Announces PDUFA Action Date for New Aggrastat Indication
Watch Medicure's latest callMedicure (TSXV:MPH) Q2 2026 Earnings Call · Replay · Aug 17Read the transcript of Medicure (TSXV:MPH) Q2 2026 Earnings CallView original source (CNW)Medicure Inc. on 6ix
Earlier from Medicure
- Medicure Reports Third Quarter 2015 Financial Results
- PI Financial Initiates Coverage on Medicure Inc. with a $5.75 Target Price - Video Research Alert on InvestmentPitch.com
- Medicure Announces Filing of sNDA for New AGGRASTAT® Indication
- Medicure Reports Second Quarter 2015 Financial Results
- Medicure Q2 Results And Conference Call Dates
Later from Medicure
- Medicure announces ANDA collaboration with Apicore
- Medicure Announces Preliminary Revenue For Fiscal 2015
- Medicure to present at Cantech Investment Conference
- Meta-Analysis of AGGRASTAT® (Tirofiban HCl) Presented at CRT 2016 Conference
- Medicure To Announce Fiscal Year 2015 Financial Results on March 30, 2016
Follow Medicure into a list and get an email when it puts out news.
Follow Medicure